Baxter emerges as frontrunner to buy KKR-backed Gland Pharma for $1.1-1.2 billion
Economic Times - 19 hours ago
MUMBAI: US pharma major Baxter has emerged as the frontrunner to buy Gland Pharma, a KKR backed drug maker, for over a billion dollars as global supply constraints have heightened strategic interests to acquire businesses that focus oninjectables ...
Baxter leads in $1 billion-plus race for India injectables maker: ET
FiercePharma - 3 hours ago
Baxter ($BAX) wants to expand in injectables and it figures that a $1 billion-plus deal for Gland Pharma could be just the ticket. The pharma giant has emerged as the one of the frontrunners to buy the injectables company, sources told The Economic Times.
No comments:
Post a Comment